Cytokines and glomerulosclerosis.
Isaka
Y
Y
First Department of Medicine, Osaka University School of Medicine, Suita, Japan.
Akagi
Y
Y
Ando
Y
Y
Tsujie
M
M
Imai
E
E
D000818:Animals; D002460:Cell Line; D002678:Chimera; D005091:Exons / Q000235:genetics; D005240:Feasibility Studies; D005353:Fibronectins / Q000037:antagonists & inhibitors / Q000235:genetics; D018014:Gene Transfer Techniques; D005923:Glomerulosclerosis, Focal Segmental / Q000503:physiopathology*; D006131:Growth Inhibitors / Q000494:pharmacology; D007141:Immunoglobulin Fc Fragments / Q000235:genetics; D009393:Nephritis / Q000378:metabolism; D017346:Protein Serine-Threonine Kinases; D012333:RNA, Messenger / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D051381:Rats; D000077294:Receptor, Transforming Growth Factor-beta Type II; D018125:Receptors, Transforming Growth Factor beta / Q000235:genetics; D011993:Recombinant Fusion Proteins / Q000494:pharmacology; D016212:Transforming Growth Factor beta / Q000494:pharmacology / Q000502:physiology*
D005353:Fibronectins; D006131:Growth Inhibitors; D007141:Immunoglobulin Fc Fragments; D012333:RNA, Messenger; D018125:Receptors, Transforming Growth Factor beta; D011993:Recombinant Fusion Proteins; D016212:Transforming Growth Factor beta; D017346:Protein Serine-Threonine Kinases; D000077294:Receptor, Transforming Growth Factor-beta Type II